Trademark: 79350973
Word
ARICEUM
Status Date
Tuesday, March 5, 2024
Registration Number
7318209
Registration Date
Tuesday, March 5, 2024
Filing Date
Monday, August 22, 2022
Published for Opposition
Tuesday, December 19, 2023
5 Pharmaceuticals for use in the treatment of cancer; pharmaceutical drugs for use in the treatment of cancer; pharmaceutical preparations for use in the treatment of cancer; injectable pharmaceuticals for use in the treatment of cancer; chemico-pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations and substances for use in the treatment of cancer; pharmaceutical preparations for human use for use in the treatment of cancer; synthetic peptides for pharmaceutical purposes for use in the diagnosis and treatment of cancer; pharmaceutical preparations for medical purposes for use in the treatment of cancer; pharmaceutical preparations for the prevention of tumours; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; radioactive substances for medical purposes; radioactive materials for medical purposes; radioactive elements for medical use
42 Pharmaceutical products development; pharmaceutical product evaluation; testing of pharmaceuticals; research of pharmaceuticals; pharmaceutical research and development; research relating to pharmaceuticals; conducting clinical trials for pharmaceutical products of others; development of pharmaceutical preparations and medicines; research on the subject of pharmaceuticals; research and development for the pharmaceutical industry; research and development in the pharmaceutical and biotechnology fields; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceutical preparations for treating malignant tumours
Jun 15, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Sep 29, 2022
Sn Assigned For Sect 66a Appl From Ib
Sep 30, 2022
New Application Office Supplied Data Entered
Oct 4, 2022
Application Filing Receipt Mailed
Jun 8, 2023
Assigned To Examiner
Jun 14, 2023
Non-Final Action Written
Jul 20, 2023
Refusal Processed By Mpu
Jul 20, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Aug 7, 2023
Refusal Processed By Ib
Nov 9, 2023
Teas Response To Office Action Received
Nov 9, 2023
Correspondence Received In Law Office
Nov 10, 2023
Teas/Email Correspondence Entered
Nov 13, 2023
Approved For Pub - Principal Register
Nov 29, 2023
Notification Of Possible Opposition Sent To Ib
Dec 19, 2023
Published For Opposition
Nov 29, 2023
Notification Of Notice Of Publication E-Mailed
Nov 29, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 19, 2023
Notification Processed By Ib
Dec 19, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 5, 2024
Registered-Principal Register
Aug 16, 2024
New Representative At Ib Received
Jun 6, 2024
Final Disposition Notice Created, To Be Sent To Ib
Mar 5, 2024
Notice Of Registration Confirmation Emailed
Jun 6, 2024
Final Disposition Notice Created, To Be Sent To Ib
Jun 6, 2024
Final Disposition Notice Created, To Be Sent To Ib
Trademark Alertz updated from USPTO on 2030-01-24
